Insider filing · UTHR
Michael Benkowitz
PRESIDENT AND COO
profile →
United Therapeutics Corporation
UTHR · Healthcare · 372 filings in 24 months
ticker →
Michael Benkowitz sold $9.1M of United Therapeutics (UTHR)
Executed Sep 2 2025, disclosed Sep 4 2025, 2 days later.
Value, as filed
$9.1M
21,727 sh across 9 lots
Executed
Sep 2 2025
the trade date, as filed
Disclosed
Sep 4 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MBMichael Benkowitz (PRESIDENT AND COO) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales, 3 filed past the two-business-day deadline), most often in United Therapeutics Corporation (UTHR). The largest single filing was $14.2M of UTHR (30,214 sh across 13 lots, as filed), executed Jan 20.
The name
UTHRHealthcare · United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Michael Benkowitz in UTHR
UTHRSALE
United Therapeutics Corporation
$6.8M14,440 sh across 2 lots
Exec Feb 23
Filed Feb 24 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $10.8M
22,500 sh across 2 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $10.7M
22,500 sh across 2 lots
Exec Feb 9
Filed Feb 10 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $10.6M
22,500 sh across 2 lots
Exec Feb 2
Filed Feb 3 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $14.2M
30,214 sh across 13 lots
Exec Jan 20
Filed Jan 28 · 5:30 PM ET † UTHRSALE United Therapeutics Corporation $6.7M
14,327 sh across 11 lots
Exec Jan 20
Filed Jan 28 · 5:30 PM ET † UTHRSALE United Therapeutics Corporation $10.8M
22,500 sh across 2 lots
Exec Jan 12
Filed Jan 13 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $3.7M
7,674 sh across 13 lots
Exec Jan 5
Filed Jan 7 · 5:30 PM ET